Sign in
Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice
Journal article   Open access

Paclitaxel Modulates TGFβ Signaling in Scleroderma Skin Grafts in Immunodeficient Mice

Xialin Liu, Shoukang Zhu, Tao Wang, Laura Hummers, Fredrick M Wigley, Pascal J Goldschmidt-Clermont and Chunming Dong
PLoS medicine, Vol.2(12), pp.1334-1342
2005-12
PMID: 16250671

Abstract

Connective Tissue Disease Dermatology Immunology and Allergy Rheumatology
In a mouse model of Systemic sclerosis low-dose paclitaxel can suppress an important disease-related pathway, that involves TGFβ and Smad, and lessen fibrosis .
url
https://doi.org/10.1371/journal.pmed.0020354View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.106 Rheumatology
1.106.1083 Systemic Sclerosis
Web Of Science research areas
Rheumatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details